{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT02301039",
      "OrgStudyIdInfo": {
        "OrgStudyId": "SARC028"
      },
      "Organization": {
        "OrgFullName": "Sarcoma Alliance for Research through Collaboration",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "SARC028: A Phase II Study of the Anti-PD1 Antibody Pembrolizumab (MK-3475) in Patients With Advanced Sarcomas",
      "OfficialTitle": "SARC028: A Phase II Study of the Anti-PD1 Antibody Pembrolizumab (MK-3475) in Patients With Advanced Sarcomas"
    },
    "StatusModule": {
      "StatusVerifiedDate": "September 2020",
      "OverallStatus": "Completed",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "March 2015",
        "StartDateType": "Actual"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "July 1, 2020",
        "PrimaryCompletionDateType": "Actual"
      },
      "CompletionDateStruct": {
        "CompletionDate": "July 1, 2020",
        "CompletionDateType": "Actual"
      },
      "StudyFirstSubmitDate": "November 17, 2014",
      "StudyFirstSubmitQCDate": "November 21, 2014",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "November 25, 2014",
        "StudyFirstPostDateType": "Estimate"
      },
      "ResultsFirstSubmitDate": "July 8, 2020",
      "ResultsFirstSubmitQCDate": "September 25, 2020",
      "ResultsFirstPostDateStruct": {
        "ResultsFirstPostDate": "September 29, 2020",
        "ResultsFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "September 25, 2020",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "September 29, 2020",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Sarcoma Alliance for Research through Collaboration",
        "LeadSponsorClass": "OTHER"
      },
      "CollaboratorList": {
        "Collaborator": [
          {
            "CollaboratorName": "Merck Sharp & Dohme Corp.",
            "CollaboratorClass": "INDUSTRY"
          }
        ]
      }
    },
    "OversightModule": {
      "OversightHasDMC": "Yes"
    },
    "DescriptionModule": {
      "BriefSummary": "The purpose of this study is to determine the efficacy of pembrolizumab in patients with advanced sarcomas.",
      "DetailedDescription": "This is a multi-institutional phase II study of pembrolizumab in patients with advanced sarcomas. This study will have two treatment groups, one group for patients with soft tissue sarcoma and one group for patients with bone sarcoma.\n\nInitial enrollment for this study included a total of 86 patients with soft tissue sarcoma and bone sarcomas.\n\nIn the expansion portion, there will be an additional 30 patients with undifferentiated pleomorphic sarcoma (UPS) and 30 patients with dedifferentiated or other high grade liposarcoma (LPS) enrolled into the study."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Soft Tissue Sarcoma",
          "Bone Sarcoma"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 2"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Non-Randomized",
        "DesignInterventionModel": "Single Group Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "144",
        "EnrollmentType": "Actual"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Soft tissue sarcoma",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Patients with the following types of soft tissue sarcoma: leiomyosarcoma, poorly differentiated/de-differentiated liposarcoma, high grade pleomorphic undifferentiated sarcoma/MFH, MPNST and synovial sarcoma). Pembrolizumab will be administered at 200 mg intravenously every 3 weeks",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Drug: Pembrolizumab"
              ]
            }
          },
          {
            "ArmGroupLabel": "Bone sarcoma",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Patients with the following types of bone sarcoma: Ewing sarcoma, osteosarcoma, and chondrosarcoma [de-differentiated or mesenchymal]. Pembrolizumab will be administered at 200 mg intravenously every 3 weeks",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Drug: Pembrolizumab"
              ]
            }
          },
          {
            "ArmGroupLabel": "Expansion",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Patients with the following types of soft tissue sarcoma: poorly differentiated/de-differentiated liposarcoma, high grade pleomorphic undifferentiated sarcoma. Pembrolizumab was administered at 200 mg intravenously every 3 weeks",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Drug: Pembrolizumab"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Drug",
            "InterventionName": "Pembrolizumab",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Bone sarcoma",
                "Expansion",
                "Soft tissue sarcoma"
              ]
            },
            "InterventionOtherNameList": {
              "InterventionOtherName": [
                "Mk-3475"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Objective Response Rate",
            "PrimaryOutcomeDescription": "The Objective Response Rate (ORR) is the percentage of patient's tumor that shrinks or disappears after treatment. ORR will be evaluated according to RECIST (Response Evaluation Criteria In Solid Tumors) 1.1, whereby Complete Response is defined as the disappearance of all target lesions and Partial Response is defined as at least a 30% decrease in the sum of the diameters of target lesions in reference to the baseline diameters. Overall Response (OR) = CR + PR.",
            "PrimaryOutcomeTimeFrame": "Assessments will be conducted at 8 weeks, up to 5 years"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Adverse Events Related to Pembrolizumab Treatment in Patients With Advanced Sarcoma, by Patient",
            "SecondaryOutcomeDescription": "Related Adverse Event is any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, or disease temporally associated with the use of a investigational product and related to the investigational product.",
            "SecondaryOutcomeTimeFrame": "Up to 5 years"
          },
          {
            "SecondaryOutcomeMeasure": "The Progression-free Survival (PFS)",
            "SecondaryOutcomeDescription": "The progression-free survival is the length of time during and after the treatment of a disease, such as cancer, that a patient lives with the disease but it does not get worse.",
            "SecondaryOutcomeTimeFrame": "up to 5 yrs"
          },
          {
            "SecondaryOutcomeMeasure": "Response Rate by Immune-related Response Criteria (Ir-RC)",
            "SecondaryOutcomeDescription": "Immune related response criteria was developed to adequately assess tumor response to immunotherapy.The irRC are based on bidimensional measurements We aimed to assess response by bidimensional measurements in patients with advanced sarcoma. Immune-related Complete Response (irCR) is the complete disappearance of all index lesions. Immune-related Partial Response (irPR) is the decrease by 50% or greater (from Baseline) in the sum of the products of the two largest perpendicular diameters of all index and new measurable lesions",
            "SecondaryOutcomeTimeFrame": "Assessment at 8 weeks, up to 5 years"
          },
          {
            "SecondaryOutcomeMeasure": "Overall Survival (OS)",
            "SecondaryOutcomeDescription": "The Overall Survival is the length of time from either the date of diagnosis or the start of treatment for a disease, such as cancer, that patients diagnosed with the disease and are still alive",
            "SecondaryOutcomeTimeFrame": "up to 5 years"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nAge ≥ 18 years (Age ≥ 12 years for patients with bone sarcomas).\nHistologically confirmed diagnosis of unresectable, recurrent, and/or metastatic high grade soft-tissue or bone sarcoma of one of the following subtypes: soft tissue sarcomas (leiomyosarcoma, poorly differentiated/de-differentiated liposarcoma, high grade pleomorphic undifferentiated sarcoma/MFH and synovial sarcoma), and bone sarcomas (Ewing sarcoma, osteosarcoma, and chondrosarcoma [de-differentiated or mesenchymal]).\nECOG Performance Status of 0 or 1.\nAt least one site of measurable disease on CT/MRI scans as defined by RECIST 1.1. Baseline imaging must be performed within 30 days of dosing.\nAt least one site of accessible disease for pre- and post-treatment core biopsies for at least 20 patients per arm on the expansion cohorts.\nPatients may have received 1-3 prior systemic therapies in the metastatic setting.\nAdequate organ function within 14 days of dosing\nMust be willing to provide and have available archival tissue for PD-L1 testing.\nWritten, voluntary informed consent.\nFertile men and women of childbearing potential must agree to use an effective method of birth control from providing signed consent and for 120 days after last study drug administration. Women of childbearing potential include pre-menopausal women and women within the first 2 years of the onset of menopause. Women of childbearing potential must have a negative pregnancy test ≤ 72 hours prior to Day 1 of study.\nEffective methods of birth control include: surgically sterile, barrier device (condom, diaphragm), contraceptive coil, intrauterine device (IUD), and abstinence.\nLife expectancy of >12 weeks.\nPatients with central nervous system disease are eligible for enrollment if they have received prior radiotherapy or surgery to sites of CNS metastatic disease and are without evidence of clinical progression for at least 4 weeks prior to screening, have no evidence of new or enlarging brain metastases, and are off steroids for at least 7 days before first dose of pembrolizumab.\n\nExclusion Criteria:\n\nPrior systemic therapy targeting PD-1: PD-L1 axis.\nPatients who are curable by conventional multidisciplinary management.\nPatients with severe and/or uncontrolled concurrent medical disease that in the opinion of the investigator could cause unacceptable safety risks or compromise compliance with the protocol.\nPatients who have received wide field radiotherapy ≤ 4 weeks or limited field radiation for palliation < 2 weeks prior to screening or who have not recovered adequately from side effects of such therapy.\nPatients who have active infections requiring therapy.\nPatients that are known to be positive for Human Immunodeficiency Virus (HIV) (HIV 1/2 antibodies), active Hepatitis B (HBsAg reactive), or Hepatitis C (HCV RNA [qualitative] is detected); patients with negative Hepatitis C antibody testing may not need RNA testing.\nPatients that have a known psychiatric or substance abuse disorder that would interfere with cooperation with the requirements of the trial.\nPatients who received systemic anti-cancer treatment prior to the first dose of study drug within the following time frames:\nPatients with active autoimmune disease or a documented history of autoimmune disease or syndrome that requires systemic steroids or immunosuppressive agents. Patients with vitiligo or resolved childhood asthma/atopy would be exception to this rule. Patients that require inhaled steroids or local steroid injections would not be excluded from the study. Patients with hypothyroidism not from autoimmune disease that is stable on hormone replacement will not be excluded from the study.\nWomen who are pregnant or nursing/breastfeeding.\nKnown hypersensitivity to pembrolizumab or another mAb.\nHas a history of (non-infectious) pneumonitis that required steroids or current pneumonitis.\nPatients with untreated central nervous system disease. Patients with controlled treated CNS lesions who have undergone surgery or stereotactic radiosurgery and stable for 4 weeks are eligible.\nInability to comply with protocol required procedures.\nPatients with medical conditions that require chronic systemic corticosteroid therapy or require any other form of immunosuppressive medication. However, patients using physiologic replacement doses of hydrocortisone, or its equivalent, will be considered eligible for this study: up to 20 mg hydrocortisone (or 5 mg of prednisone) in the morning and 10 mg hydrocortisone (or 2.5 mg prednisone) in the evening.\nPatients with the risk factors for bowel obstruction or bowel perforation (examples include but not limited to a history of acute diverticulitis, intra-abdominal abscess, abdominal carcinomatosis).\nPatients who have received a live vaccine within 30 days prior to the first dose of trial treatment.",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "12 Years",
      "StdAgeList": {
        "StdAge": [
          "Child",
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Hussein Tawbi, MD, PhD",
            "OverallOfficialAffiliation": "The University of Texas MD Anderson Cancer Center",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "University of Southern California",
            "LocationCity": "Los Angeles",
            "LocationState": "California",
            "LocationZip": "90033",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Medstar Health Research Institute",
            "LocationCity": "Washington",
            "LocationState": "District of Columbia",
            "LocationZip": "20010",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mayo Clinic Florida",
            "LocationCity": "Jacksonville",
            "LocationState": "Florida",
            "LocationZip": "32224",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "H. Lee Moffitt Cancer Center",
            "LocationCity": "Tampa",
            "LocationState": "Florida",
            "LocationZip": "33612",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "University of Michigan",
            "LocationCity": "Ann Arbor",
            "LocationState": "Michigan",
            "LocationZip": "48109",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mayo Clinic Cancer Center",
            "LocationCity": "Rochester",
            "LocationState": "Minnesota",
            "LocationZip": "55905",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Washington University in St. Louis",
            "LocationCity": "Saint Louis",
            "LocationState": "Missouri",
            "LocationZip": "63110",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Memorial Sloan Kettering Cancer Center",
            "LocationCity": "New York",
            "LocationState": "New York",
            "LocationZip": "10065",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Duke University",
            "LocationCity": "Durham",
            "LocationState": "North Carolina",
            "LocationZip": "27705",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Oregon Health and Science University",
            "LocationCity": "Portland",
            "LocationState": "Oregon",
            "LocationZip": "97201",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Fox Chase Cancer Center",
            "LocationCity": "Philadelphia",
            "LocationState": "Pennsylvania",
            "LocationZip": "19111",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "UPMC Hillman Cancer Center",
            "LocationCity": "Pittsburgh",
            "LocationState": "Pennsylvania",
            "LocationZip": "15232",
            "LocationCountry": "United States"
          }
        ]
      }
    },
    "ReferencesModule": {
      "ReferenceList": {
        "Reference": [
          {
            "ReferencePMID": "28988646",
            "ReferenceType": "derived",
            "ReferenceCitation": "Tawbi HA, Burgess M, Bolejack V, Van Tine BA, Schuetze SM, Hu J, D'Angelo S, Attia S, Riedel RF, Priebat DA, Movva S, Davis LE, Okuno SH, Reed DR, Crowley J, Butterfield LH, Salazar R, Rodriguez-Canales J, Lazar AJ, Wistuba II, Baker LH, Maki RG, Reinke D, Patel S. Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial. Lancet Oncol. 2017 Nov;18(11):1493-1501. doi: 10.1016/S1470-2045(17)30624-1. Epub 2017 Oct 4. Erratum in: Lancet Oncol. 2017 Dec;18(12 ):e711. Erratum in: Lancet Oncol. 2018 Jan;19(1):e8."
          }
        ]
      }
    },
    "IPDSharingStatementModule": {
      "IPDSharing": "No"
    }
  },
  "ResultsSection": {
    "ParticipantFlowModule": {
      "FlowGroupList": {
        "FlowGroup": [
          {
            "FlowGroupId": "FG000",
            "FlowGroupTitle": "Soft Tissue Sarcoma",
            "FlowGroupDescription": "Patients with the following types of soft tissue sarcoma: leiomyosarcoma, poorly differentiated/de-differentiated liposarcoma, high grade pleomorphic undifferentiated sarcoma/MFH, MPNST and synovial sarcoma). Pembrolizumab was administered at 200 mg intravenously every 3 weeks\n\nPembrolizumab"
          },
          {
            "FlowGroupId": "FG001",
            "FlowGroupTitle": "Bone Sarcoma",
            "FlowGroupDescription": "Patients with the following types of bone sarcoma: Ewing sarcoma, osteosarcoma, and chondrosarcoma [de-differentiated or mesenchymal]. Pembrolizumab was administered at 200 mg intravenously every 3 weeks\n\nPembrolizumab"
          },
          {
            "FlowGroupId": "FG002",
            "FlowGroupTitle": "Expansion Cohort",
            "FlowGroupDescription": "Patients with the following types of soft tissue sarcoma: poorly differentiated/de-differentiated liposarcoma, high grade pleomorphic undifferentiated sarcoma. Pembrolizumab was administered at 200 mg intravenously every 3 weeks"
          }
        ]
      },
      "FlowPeriodList": {
        "FlowPeriod": [
          {
            "FlowPeriodTitle": "Overall Study",
            "FlowMilestoneList": {
              "FlowMilestone": [
                {
                  "FlowMilestoneType": "STARTED",
                  "FlowAchievementList": {
                    "FlowAchievement": [
                      {
                        "FlowAchievementGroupId": "FG000",
                        "FlowAchievementNumSubjects": "42"
                      },
                      {
                        "FlowAchievementGroupId": "FG001",
                        "FlowAchievementNumSubjects": "42"
                      },
                      {
                        "FlowAchievementGroupId": "FG002",
                        "FlowAchievementNumSubjects": "60"
                      }
                    ]
                  }
                },
                {
                  "FlowMilestoneType": "COMPLETED",
                  "FlowAchievementList": {
                    "FlowAchievement": [
                      {
                        "FlowAchievementGroupId": "FG000",
                        "FlowAchievementNumSubjects": "42"
                      },
                      {
                        "FlowAchievementGroupId": "FG001",
                        "FlowAchievementNumSubjects": "42"
                      },
                      {
                        "FlowAchievementGroupId": "FG002",
                        "FlowAchievementNumSubjects": "60"
                      }
                    ]
                  }
                },
                {
                  "FlowMilestoneType": "NOT COMPLETED",
                  "FlowAchievementList": {
                    "FlowAchievement": [
                      {
                        "FlowAchievementGroupId": "FG000",
                        "FlowAchievementNumSubjects": "0"
                      },
                      {
                        "FlowAchievementGroupId": "FG001",
                        "FlowAchievementNumSubjects": "0"
                      },
                      {
                        "FlowAchievementGroupId": "FG002",
                        "FlowAchievementNumSubjects": "0"
                      }
                    ]
                  }
                }
              ]
            }
          }
        ]
      }
    },
    "BaselineCharacteristicsModule": {
      "BaselineGroupList": {
        "BaselineGroup": [
          {
            "BaselineGroupId": "BG000",
            "BaselineGroupTitle": "Soft Tissue Sarcoma",
            "BaselineGroupDescription": "Patients with the following types of soft tissue sarcoma: leiomyosarcoma, poorly differentiated/de-differentiated liposarcoma, high grade pleomorphic undifferentiated sarcoma/MFH, MPNST and synovial sarcoma). Pembrolizumab will be administered at 200 mg intravenously every 3 weeks\n\nPembrolizumab"
          },
          {
            "BaselineGroupId": "BG001",
            "BaselineGroupTitle": "Bone Sarcoma",
            "BaselineGroupDescription": "Patients with the following types of bone sarcoma: Ewing sarcoma, osteosarcoma, and chondrosarcoma [de-differentiated or mesenchymal]. Pembrolizumab will be administered at 200 mg intravenously every 3 weeks\n\nPembrolizumab"
          },
          {
            "BaselineGroupId": "BG002",
            "BaselineGroupTitle": "Expansion",
            "BaselineGroupDescription": "Patients with the following types of soft tissue sarcoma: Liposarcoma and Pleomorphic sarcoma"
          },
          {
            "BaselineGroupId": "BG003",
            "BaselineGroupTitle": "Total",
            "BaselineGroupDescription": "Total of all reporting groups"
          }
        ]
      },
      "BaselineDenomList": {
        "BaselineDenom": [
          {
            "BaselineDenomUnits": "Participants",
            "BaselineDenomCountList": {
              "BaselineDenomCount": [
                {
                  "BaselineDenomCountGroupId": "BG000",
                  "BaselineDenomCountValue": "42"
                },
                {
                  "BaselineDenomCountGroupId": "BG001",
                  "BaselineDenomCountValue": "42"
                },
                {
                  "BaselineDenomCountGroupId": "BG002",
                  "BaselineDenomCountValue": "60"
                },
                {
                  "BaselineDenomCountGroupId": "BG003",
                  "BaselineDenomCountValue": "144"
                }
              ]
            }
          }
        ]
      },
      "BaselineMeasureList": {
        "BaselineMeasure": [
          {
            "BaselineMeasureTitle": "Age, Categorical",
            "BaselineMeasureParamType": "Count of Participants",
            "BaselineMeasureUnitOfMeasure": "Participants",
            "BaselineClassList": {
              "BaselineClass": [
                {
                  "BaselineCategoryList": {
                    "BaselineCategory": [
                      {
                        "BaselineCategoryTitle": "<=18 years",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "1"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "6"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "0"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "7"
                            }
                          ]
                        }
                      },
                      {
                        "BaselineCategoryTitle": "Between 18 and 65 years",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "32"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "34"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "38"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "104"
                            }
                          ]
                        }
                      },
                      {
                        "BaselineCategoryTitle": ">=65 years",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "9"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "2"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "22"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "33"
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "BaselineMeasureTitle": "Sex: Female, Male",
            "BaselineMeasureParamType": "Count of Participants",
            "BaselineMeasureUnitOfMeasure": "Participants",
            "BaselineClassList": {
              "BaselineClass": [
                {
                  "BaselineCategoryList": {
                    "BaselineCategory": [
                      {
                        "BaselineCategoryTitle": "Female",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "15"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "16"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "17"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "48"
                            }
                          ]
                        }
                      },
                      {
                        "BaselineCategoryTitle": "Male",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "27"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "26"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "43"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "96"
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "BaselineMeasureTitle": "Ethnicity (NIH/OMB)",
            "BaselineMeasureParamType": "Count of Participants",
            "BaselineMeasureUnitOfMeasure": "Participants",
            "BaselineClassList": {
              "BaselineClass": [
                {
                  "BaselineCategoryList": {
                    "BaselineCategory": [
                      {
                        "BaselineCategoryTitle": "Hispanic or Latino",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "2"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "1"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "5"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "8"
                            }
                          ]
                        }
                      },
                      {
                        "BaselineCategoryTitle": "Not Hispanic or Latino",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "36"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "37"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "53"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "126"
                            }
                          ]
                        }
                      },
                      {
                        "BaselineCategoryTitle": "Unknown or Not Reported",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "4"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "4"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "2"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "10"
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "BaselineMeasureTitle": "Race (NIH/OMB)",
            "BaselineMeasureParamType": "Count of Participants",
            "BaselineMeasureUnitOfMeasure": "Participants",
            "BaselineClassList": {
              "BaselineClass": [
                {
                  "BaselineCategoryList": {
                    "BaselineCategory": [
                      {
                        "BaselineCategoryTitle": "American Indian or Alaska Native",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "0"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "1"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "0"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "1"
                            }
                          ]
                        }
                      },
                      {
                        "BaselineCategoryTitle": "Asian",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "2"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "1"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "1"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "4"
                            }
                          ]
                        }
                      },
                      {
                        "BaselineCategoryTitle": "Native Hawaiian or Other Pacific Islander",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "0"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "0"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "0"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "0"
                            }
                          ]
                        }
                      },
                      {
                        "BaselineCategoryTitle": "Black or African American",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "3"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "2"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "4"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "9"
                            }
                          ]
                        }
                      },
                      {
                        "BaselineCategoryTitle": "White",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "36"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "35"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "51"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "122"
                            }
                          ]
                        }
                      },
                      {
                        "BaselineCategoryTitle": "More than one race",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "0"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "1"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "0"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "1"
                            }
                          ]
                        }
                      },
                      {
                        "BaselineCategoryTitle": "Unknown or Not Reported",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "1"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "2"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "4"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "7"
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          }
        ]
      }
    },
    "OutcomeMeasuresModule": {
      "OutcomeMeasureList": {
        "OutcomeMeasure": [
          {
            "OutcomeMeasureType": "Primary",
            "OutcomeMeasureTitle": "Objective Response Rate",
            "OutcomeMeasureDescription": "The Objective Response Rate (ORR) is the percentage of patient's tumor that shrinks or disappears after treatment. ORR will be evaluated according to RECIST (Response Evaluation Criteria In Solid Tumors) 1.1, whereby Complete Response is defined as the disappearance of all target lesions and Partial Response is defined as at least a 30% decrease in the sum of the diameters of target lesions in reference to the baseline diameters. Overall Response (OR) = CR + PR.",
            "OutcomeMeasurePopulationDescription": "There were 40 of 42 patients in the soft tissue sarcoma cohort who were evaluable for response. There were 40 of 42 patients in the bone sarcoma cohort who were evaluable for response. There were 53 of 60 patients in the expansion cohort who were evaluable for response.",
            "OutcomeMeasureReportingStatus": "Posted",
            "OutcomeMeasureParamType": "Count of Participants",
            "OutcomeMeasureUnitOfMeasure": "Participants",
            "OutcomeMeasureTimeFrame": "Assessments will be conducted at 8 weeks, up to 5 years",
            "OutcomeGroupList": {
              "OutcomeGroup": [
                {
                  "OutcomeGroupId": "OG000",
                  "OutcomeGroupTitle": "Soft Tissue Sarcoma",
                  "OutcomeGroupDescription": "Patients with the following types of soft tissue sarcoma: leiomyosarcoma, poorly differentiated/de-differentiated liposarcoma, high grade pleomorphic undifferentiated sarcoma/MFH, MPNST and synovial sarcoma). Pembrolizumab was administered at 200 mg intravenously every 3 weeks\n\nPembrolizumab"
                },
                {
                  "OutcomeGroupId": "OG001",
                  "OutcomeGroupTitle": "Bone Sarcoma",
                  "OutcomeGroupDescription": "Patients with the following types of bone sarcoma: Ewing sarcoma, osteosarcoma, and chondrosarcoma [de-differentiated or mesenchymal]. Pembrolizumab was administered at 200 mg intravenously every 3 weeks\n\nPembrolizumab"
                },
                {
                  "OutcomeGroupId": "OG002",
                  "OutcomeGroupTitle": "Expansion Cohort",
                  "OutcomeGroupDescription": "Patients with the following types of soft tissue sarcoma: poorly differentiated/de-differentiated liposarcoma, high grade pleomorphic undifferentiated sarcoma. Pembrolizumab was administered at 200 mg intravenously every 3 weeks"
                }
              ]
            },
            "OutcomeDenomList": {
              "OutcomeDenom": [
                {
                  "OutcomeDenomUnits": "Participants",
                  "OutcomeDenomCountList": {
                    "OutcomeDenomCount": [
                      {
                        "OutcomeDenomCountGroupId": "OG000",
                        "OutcomeDenomCountValue": "40"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG001",
                        "OutcomeDenomCountValue": "40"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG002",
                        "OutcomeDenomCountValue": "53"
                      }
                    ]
                  }
                }
              ]
            },
            "OutcomeClassList": {
              "OutcomeClass": [
                {
                  "OutcomeCategoryList": {
                    "OutcomeCategory": [
                      {
                        "OutcomeMeasurementList": {
                          "OutcomeMeasurement": [
                            {
                              "OutcomeMeasurementGroupId": "OG000",
                              "OutcomeMeasurementValue": "7"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG001",
                              "OutcomeMeasurementValue": "2"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG002",
                              "OutcomeMeasurementValue": "7"
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            },
            "OutcomeAnalysisList": {
              "OutcomeAnalysis": [
                {
                  "OutcomeAnalysisGroupIdList": {
                    "OutcomeAnalysisGroupId": [
                      "OG000"
                    ]
                  },
                  "OutcomeAnalysisGroupDescription": "An objective response rate of 25% will be considered clinically meaningful and a response rate less than 10% will be considered lack of efficacy. The treatment will be considered a success if 8 or more of 40 enrolled patients have a PR or better by RECIST 1.1.",
                  "OutcomeAnalysisNonInferiorityType": "Superiority",
                  "OutcomeAnalysisNonInferiorityComment": "An objective response rate of 25% will be considered clinically meaningful and a response rate less than 10% will be considered lack of efficacy. The treatment will be considered a success if 8 or more of 40 enrolled patients have a PR or better by RECIST 1.1.",
                  "OutcomeAnalysisParamType": "Binomial estimate of response rate of PR",
                  "OutcomeAnalysisParamValue": "17.5",
                  "OutcomeAnalysisCIPctValue": "95",
                  "OutcomeAnalysisCINumSides": "2-Sided",
                  "OutcomeAnalysisCILowerLimit": "7.3",
                  "OutcomeAnalysisCIUpperLimit": "32.8",
                  "OutcomeAnalysisEstimateComment": "Clopper-Pearson (Exact) Confidence Interval. Excluded from rate due to no response evaluation: Soft Tissue: 2; Bone: 2; Expansion: 7 patients"
                },
                {
                  "OutcomeAnalysisGroupIdList": {
                    "OutcomeAnalysisGroupId": [
                      "OG001"
                    ]
                  },
                  "OutcomeAnalysisGroupDescription": "An objective response rate of 25% will be considered clinically meaningful and a response rate less than 10% will be considered lack of efficacy. The treatment will be considered a success if 8 or more of 40 enrolled patients have a PR or better by RECIST 1.1.",
                  "OutcomeAnalysisNonInferiorityType": "Superiority",
                  "OutcomeAnalysisParamType": "Binomial estimate of response rate of PR",
                  "OutcomeAnalysisParamValue": "5.0",
                  "OutcomeAnalysisCIPctValue": "95",
                  "OutcomeAnalysisCINumSides": "2-Sided",
                  "OutcomeAnalysisCILowerLimit": "1.0",
                  "OutcomeAnalysisCIUpperLimit": "16.9",
                  "OutcomeAnalysisEstimateComment": "Clopper-Pearson exact confidence interval; Excluded from rate due to no response evaluation: Soft Tissue: 2; Bone: 2; Expansion: 7 patients"
                },
                {
                  "OutcomeAnalysisGroupIdList": {
                    "OutcomeAnalysisGroupId": [
                      "OG002"
                    ]
                  },
                  "OutcomeAnalysisGroupDescription": "An objective response rate of 25% will be considered clinically meaningful and a response rate less than 10% will be considered lack of efficacy. The treatment will be considered a success if 8 or more of 40 enrolled patients have a PR or better by RECIST 1.1.",
                  "OutcomeAnalysisNonInferiorityType": "Superiority",
                  "OutcomeAnalysisParamType": "Binomial estimate of response rate of PR",
                  "OutcomeAnalysisParamValue": "13.0",
                  "OutcomeAnalysisCIPctValue": "95",
                  "OutcomeAnalysisCINumSides": "2-Sided",
                  "OutcomeAnalysisCILowerLimit": "5.5",
                  "OutcomeAnalysisCIUpperLimit": "25.3",
                  "OutcomeAnalysisEstimateComment": "Clopper-Pearson (Exact) Confidence Interval Excluded from rate due to no response evaluation: Soft Tissue: 2; Bone: 2; Expansion: 7 patients"
                }
              ]
            }
          },
          {
            "OutcomeMeasureType": "Secondary",
            "OutcomeMeasureTitle": "Adverse Events Related to Pembrolizumab Treatment in Patients With Advanced Sarcoma, by Patient",
            "OutcomeMeasureDescription": "Related Adverse Event is any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, or disease temporally associated with the use of a investigational product and related to the investigational product.",
            "OutcomeMeasureReportingStatus": "Posted",
            "OutcomeMeasureParamType": "Number",
            "OutcomeMeasureUnitOfMeasure": "Grade 3 or higher treatment related AEs",
            "OutcomeMeasureTimeFrame": "Up to 5 years",
            "OutcomeGroupList": {
              "OutcomeGroup": [
                {
                  "OutcomeGroupId": "OG000",
                  "OutcomeGroupTitle": "Soft Tissue Sarcoma",
                  "OutcomeGroupDescription": "Patients with the following types of soft tissue sarcoma: leiomyosarcoma, poorly differentiated/de-differentiated liposarcoma, high grade pleomorphic undifferentiated sarcoma/MFH, MPNST and synovial sarcoma). Pembrolizumab was administered at 200 mg intravenously every 3 weeks\n\nPembrolizumab"
                },
                {
                  "OutcomeGroupId": "OG001",
                  "OutcomeGroupTitle": "Bone Sarcoma",
                  "OutcomeGroupDescription": "Patients with the following types of bone sarcoma: Ewing sarcoma, osteosarcoma, and chondrosarcoma [de-differentiated or mesenchymal]. Pembrolizumab was administered at 200 mg intravenously every 3 weeks\n\nPembrolizumab"
                },
                {
                  "OutcomeGroupId": "OG002",
                  "OutcomeGroupTitle": "Expansion Cohort",
                  "OutcomeGroupDescription": "Patients with the following types of soft tissue sarcoma: poorly differentiated/de-differentiated liposarcoma, high grade pleomorphic undifferentiated sarcoma. Pembrolizumab was administered at 200 mg intravenously every 3 weeks"
                }
              ]
            },
            "OutcomeDenomList": {
              "OutcomeDenom": [
                {
                  "OutcomeDenomUnits": "Participants",
                  "OutcomeDenomCountList": {
                    "OutcomeDenomCount": [
                      {
                        "OutcomeDenomCountGroupId": "OG000",
                        "OutcomeDenomCountValue": "42"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG001",
                        "OutcomeDenomCountValue": "42"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG002",
                        "OutcomeDenomCountValue": "60"
                      }
                    ]
                  }
                }
              ]
            },
            "OutcomeClassList": {
              "OutcomeClass": [
                {
                  "OutcomeCategoryList": {
                    "OutcomeCategory": [
                      {
                        "OutcomeMeasurementList": {
                          "OutcomeMeasurement": [
                            {
                              "OutcomeMeasurementGroupId": "OG000",
                              "OutcomeMeasurementValue": "6"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG001",
                              "OutcomeMeasurementValue": "9"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG002",
                              "OutcomeMeasurementValue": "10"
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "OutcomeMeasureType": "Secondary",
            "OutcomeMeasureTitle": "The Progression-free Survival (PFS)",
            "OutcomeMeasureDescription": "The progression-free survival is the length of time during and after the treatment of a disease, such as cancer, that a patient lives with the disease but it does not get worse.",
            "OutcomeMeasureReportingStatus": "Posted",
            "OutcomeMeasureParamType": "Median",
            "OutcomeMeasureDispersionType": "95% Confidence Interval",
            "OutcomeMeasureUnitOfMeasure": "weeks",
            "OutcomeMeasureTimeFrame": "up to 5 yrs",
            "OutcomeGroupList": {
              "OutcomeGroup": [
                {
                  "OutcomeGroupId": "OG000",
                  "OutcomeGroupTitle": "Soft Tissue Sarcoma",
                  "OutcomeGroupDescription": "Patients with the following types of soft tissue sarcoma: leiomyosarcoma, poorly differentiated/de-differentiated liposarcoma, high grade pleomorphic undifferentiated sarcoma/MFH, MPNST and synovial sarcoma). Pembrolizumab was administered at 200 mg intravenously every 3 weeks\n\nPembrolizumab"
                },
                {
                  "OutcomeGroupId": "OG001",
                  "OutcomeGroupTitle": "Bone Sarcoma",
                  "OutcomeGroupDescription": "Patients with the following types of bone sarcoma: Ewing sarcoma, osteosarcoma, and chondrosarcoma [de-differentiated or mesenchymal]. Pembrolizumab was administered at 200 mg intravenously every 3 weeks\n\nPembrolizumab"
                },
                {
                  "OutcomeGroupId": "OG002",
                  "OutcomeGroupTitle": "Expansion Cohort",
                  "OutcomeGroupDescription": "Patients with the following types of soft tissue sarcoma: poorly differentiated/de-differentiated liposarcoma, high grade pleomorphic undifferentiated sarcoma. Pembrolizumab was administered at 200 mg intravenously every 3 weeks"
                }
              ]
            },
            "OutcomeDenomList": {
              "OutcomeDenom": [
                {
                  "OutcomeDenomUnits": "Participants",
                  "OutcomeDenomCountList": {
                    "OutcomeDenomCount": [
                      {
                        "OutcomeDenomCountGroupId": "OG000",
                        "OutcomeDenomCountValue": "37"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG001",
                        "OutcomeDenomCountValue": "39"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG002",
                        "OutcomeDenomCountValue": "53"
                      }
                    ]
                  }
                }
              ]
            },
            "OutcomeClassList": {
              "OutcomeClass": [
                {
                  "OutcomeCategoryList": {
                    "OutcomeCategory": [
                      {
                        "OutcomeMeasurementList": {
                          "OutcomeMeasurement": [
                            {
                              "OutcomeMeasurementGroupId": "OG000",
                              "OutcomeMeasurementValue": "18",
                              "OutcomeMeasurementLowerLimit": "8",
                              "OutcomeMeasurementUpperLimit": "22"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG001",
                              "OutcomeMeasurementValue": "8",
                              "OutcomeMeasurementLowerLimit": "7",
                              "OutcomeMeasurementUpperLimit": "9"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG002",
                              "OutcomeMeasurementValue": "8",
                              "OutcomeMeasurementLowerLimit": "7",
                              "OutcomeMeasurementUpperLimit": "13"
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "OutcomeMeasureType": "Secondary",
            "OutcomeMeasureTitle": "Response Rate by Immune-related Response Criteria (Ir-RC)",
            "OutcomeMeasureDescription": "Immune related response criteria was developed to adequately assess tumor response to immunotherapy.The irRC are based on bidimensional measurements We aimed to assess response by bidimensional measurements in patients with advanced sarcoma. Immune-related Complete Response (irCR) is the complete disappearance of all index lesions. Immune-related Partial Response (irPR) is the decrease by 50% or greater (from Baseline) in the sum of the products of the two largest perpendicular diameters of all index and new measurable lesions",
            "OutcomeMeasurePopulationDescription": "There were 30 out of 40 total patients evaluable for response in the soft tissue sarcoma cohort. There were 30 out of 40 total patients evaluable for response in the soft tissue sarcoma cohort. There were 52 out of 60 total patients evaluable for response in the soft tissue sarcoma cohort.",
            "OutcomeMeasureReportingStatus": "Posted",
            "OutcomeMeasureParamType": "Count of Participants",
            "OutcomeMeasureUnitOfMeasure": "Participants",
            "OutcomeMeasureTimeFrame": "Assessment at 8 weeks, up to 5 years",
            "OutcomeGroupList": {
              "OutcomeGroup": [
                {
                  "OutcomeGroupId": "OG000",
                  "OutcomeGroupTitle": "Soft Tissue Sarcoma",
                  "OutcomeGroupDescription": "Patients with the following types of soft tissue sarcoma: leiomyosarcoma, poorly differentiated/de-differentiated liposarcoma, high grade pleomorphic undifferentiated sarcoma/MFH, MPNST and synovial sarcoma). Pembrolizumab was administered at 200 mg intravenously every 3 weeks\n\nPembrolizumab"
                },
                {
                  "OutcomeGroupId": "OG001",
                  "OutcomeGroupTitle": "Bone Sarcoma",
                  "OutcomeGroupDescription": "Patients with the following types of bone sarcoma: Ewing sarcoma, osteosarcoma, and chondrosarcoma [de-differentiated or mesenchymal]. Pembrolizumab was administered at 200 mg intravenously every 3 weeks\n\nPembrolizumab"
                },
                {
                  "OutcomeGroupId": "OG002",
                  "OutcomeGroupTitle": "Expansion Cohort",
                  "OutcomeGroupDescription": "Patients with the following types of soft tissue sarcoma: poorly differentiated/de-differentiated liposarcoma, high grade pleomorphic undifferentiated sarcoma. Pembrolizumab was administered at 200 mg intravenously every 3 weeks"
                }
              ]
            },
            "OutcomeDenomList": {
              "OutcomeDenom": [
                {
                  "OutcomeDenomUnits": "Participants",
                  "OutcomeDenomCountList": {
                    "OutcomeDenomCount": [
                      {
                        "OutcomeDenomCountGroupId": "OG000",
                        "OutcomeDenomCountValue": "30"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG001",
                        "OutcomeDenomCountValue": "30"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG002",
                        "OutcomeDenomCountValue": "52"
                      }
                    ]
                  }
                }
              ]
            },
            "OutcomeClassList": {
              "OutcomeClass": [
                {
                  "OutcomeClassTitle": "irCR",
                  "OutcomeCategoryList": {
                    "OutcomeCategory": [
                      {
                        "OutcomeMeasurementList": {
                          "OutcomeMeasurement": [
                            {
                              "OutcomeMeasurementGroupId": "OG000",
                              "OutcomeMeasurementValue": "1"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG001",
                              "OutcomeMeasurementValue": "0"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG002",
                              "OutcomeMeasurementValue": "2"
                            }
                          ]
                        }
                      }
                    ]
                  }
                },
                {
                  "OutcomeClassTitle": "irPR",
                  "OutcomeCategoryList": {
                    "OutcomeCategory": [
                      {
                        "OutcomeMeasurementList": {
                          "OutcomeMeasurement": [
                            {
                              "OutcomeMeasurementGroupId": "OG000",
                              "OutcomeMeasurementValue": "2"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG001",
                              "OutcomeMeasurementValue": "2"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG002",
                              "OutcomeMeasurementValue": "7"
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "OutcomeMeasureType": "Secondary",
            "OutcomeMeasureTitle": "Overall Survival (OS)",
            "OutcomeMeasureDescription": "The Overall Survival is the length of time from either the date of diagnosis or the start of treatment for a disease, such as cancer, that patients diagnosed with the disease and are still alive",
            "OutcomeMeasureReportingStatus": "Posted",
            "OutcomeMeasureParamType": "Median",
            "OutcomeMeasureDispersionType": "95% Confidence Interval",
            "OutcomeMeasureUnitOfMeasure": "weeks",
            "OutcomeMeasureTimeFrame": "up to 5 years",
            "OutcomeGroupList": {
              "OutcomeGroup": [
                {
                  "OutcomeGroupId": "OG000",
                  "OutcomeGroupTitle": "Soft Tissue Sarcoma",
                  "OutcomeGroupDescription": "Patients with the following types of soft tissue sarcoma: leiomyosarcoma, poorly differentiated/de-differentiated liposarcoma, high grade pleomorphic undifferentiated sarcoma/MFH, MPNST and synovial sarcoma). Pembrolizumab was administered at 200 mg intravenously every 3 weeks\n\nPembrolizumab"
                },
                {
                  "OutcomeGroupId": "OG001",
                  "OutcomeGroupTitle": "Bone Sarcoma",
                  "OutcomeGroupDescription": "Patients with the following types of bone sarcoma: Ewing sarcoma, osteosarcoma, and chondrosarcoma [de-differentiated or mesenchymal]. Pembrolizumab was administered at 200 mg intravenously every 3 weeks\n\nPembrolizumab"
                },
                {
                  "OutcomeGroupId": "OG002",
                  "OutcomeGroupTitle": "Expansion Cohort",
                  "OutcomeGroupDescription": "Patients with the following types of soft tissue sarcoma: poorly differentiated/de-differentiated liposarcoma, high grade pleomorphic undifferentiated sarcoma. Pembrolizumab was administered at 200 mg intravenously every 3 weeks"
                }
              ]
            },
            "OutcomeDenomList": {
              "OutcomeDenom": [
                {
                  "OutcomeDenomUnits": "Participants",
                  "OutcomeDenomCountList": {
                    "OutcomeDenomCount": [
                      {
                        "OutcomeDenomCountGroupId": "OG000",
                        "OutcomeDenomCountValue": "42"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG001",
                        "OutcomeDenomCountValue": "42"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG002",
                        "OutcomeDenomCountValue": "60"
                      }
                    ]
                  }
                }
              ]
            },
            "OutcomeClassList": {
              "OutcomeClass": [
                {
                  "OutcomeCategoryList": {
                    "OutcomeCategory": [
                      {
                        "OutcomeMeasurementList": {
                          "OutcomeMeasurement": [
                            {
                              "OutcomeMeasurementGroupId": "OG000",
                              "OutcomeMeasurementValue": "49",
                              "OutcomeMeasurementLowerLimit": "34",
                              "OutcomeMeasurementUpperLimit": "73"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG001",
                              "OutcomeMeasurementValue": "52",
                              "OutcomeMeasurementLowerLimit": "40",
                              "OutcomeMeasurementUpperLimit": "72"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG002",
                              "OutcomeMeasurementValue": "57",
                              "OutcomeMeasurementLowerLimit": "33",
                              "OutcomeMeasurementUpperLimit": "86"
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          }
        ]
      }
    },
    "AdverseEventsModule": {
      "EventsFrequencyThreshold": "1",
      "EventsTimeFrame": "Adverse Event data is collected beginning from the time of treatment through 30 days following cessation of treatment or the initiation of a new anti-cancer therapy, whichever is earlier.",
      "EventGroupList": {
        "EventGroup": [
          {
            "EventGroupId": "EG000",
            "EventGroupTitle": "Soft Tissue Sarcoma",
            "EventGroupDescription": "Patients with the following types of soft tissue sarcoma: leiomyosarcoma, poorly differentiated/de-differentiated liposarcoma, high grade pleomorphic undifferentiated sarcoma/MFH, MPNST and synovial sarcoma). Pembrolizumab will be administered at 200 mg intravenously every 3 weeks\n\nPembrolizumab",
            "EventGroupDeathsNumAffected": "4",
            "EventGroupDeathsNumAtRisk": "42",
            "EventGroupSeriousNumAffected": "19",
            "EventGroupSeriousNumAtRisk": "42",
            "EventGroupOtherNumAffected": "40",
            "EventGroupOtherNumAtRisk": "42"
          },
          {
            "EventGroupId": "EG001",
            "EventGroupTitle": "Bone Sarcoma",
            "EventGroupDescription": "Patients with the following types of bone sarcoma: Ewing sarcoma, osteosarcoma, and chondrosarcoma [de-differentiated or mesenchymal]. Pembrolizumab will be administered at 200 mg intravenously every 3 weeks\n\nPembrolizumab",
            "EventGroupDeathsNumAffected": "2",
            "EventGroupDeathsNumAtRisk": "42",
            "EventGroupSeriousNumAffected": "15",
            "EventGroupSeriousNumAtRisk": "42",
            "EventGroupOtherNumAffected": "42",
            "EventGroupOtherNumAtRisk": "42"
          },
          {
            "EventGroupId": "EG002",
            "EventGroupTitle": "Expansion",
            "EventGroupDescription": "Patients with the following types of soft tissue sarcoma: Undifferentiated pleomorphic sarcoma (UPS) and de-differentiated liposarcoma (LPS). Pembrolizumab will be administered at 200 mg intravenously every 3 weeks",
            "EventGroupDeathsNumAffected": "2",
            "EventGroupDeathsNumAtRisk": "60",
            "EventGroupSeriousNumAffected": "17",
            "EventGroupSeriousNumAtRisk": "60",
            "EventGroupOtherNumAffected": "58",
            "EventGroupOtherNumAtRisk": "60"
          }
        ]
      },
      "SeriousEventList": {
        "SeriousEvent": [
          {
            "SeriousEventTerm": "Bronchopulmonary hemmorhage",
            "SeriousEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "SeriousEventSourceVocabulary": "CTCAE (4.0)",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumEvents": "1",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Duodenal Perforation",
            "SeriousEventOrganSystem": "Gastrointestinal disorders",
            "SeriousEventSourceVocabulary": "CTCAE (4.0)",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumEvents": "1",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Sepsis",
            "SeriousEventOrganSystem": "Infections and infestations",
            "SeriousEventSourceVocabulary": "CTCAE (4.0)",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumEvents": "1",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumEvents": "1",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Neoplasms, benign, malignant and unspecified",
            "SeriousEventOrganSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
            "SeriousEventSourceVocabulary": "CTCAE (4.0)",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumEvents": "2",
                  "SeriousEventStatsNumAffected": "2",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumEvents": "1",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumEvents": "2",
                  "SeriousEventStatsNumAffected": "2",
                  "SeriousEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS - OTHER, SPECIFY",
            "SeriousEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "SeriousEventSourceVocabulary": "CTCAE (4.0)",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumEvents": "1",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Dyspnea",
            "SeriousEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "SeriousEventSourceVocabulary": "CTCAE (4.0)",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumEvents": "2",
                  "SeriousEventStatsNumAffected": "2",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumEvents": "1",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumEvents": "1",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Hypoxia",
            "SeriousEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "SeriousEventSourceVocabulary": "CTCAE (4.0)",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumEvents": "1",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Laryngeal hemmorrhage",
            "SeriousEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "SeriousEventSourceVocabulary": "CTCAE (4.0)",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumEvents": "1",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Pleural Effusion",
            "SeriousEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "SeriousEventSourceVocabulary": "CTCAE (4.0)",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumEvents": "2",
                  "SeriousEventStatsNumAffected": "2",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumEvents": "1",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Pneumonitis",
            "SeriousEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "SeriousEventSourceVocabulary": "CTCAE (4.0)",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumEvents": "1",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Nervous system disorders, other",
            "SeriousEventOrganSystem": "Nervous system disorders",
            "SeriousEventSourceVocabulary": "CTCAE (4.0)",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumEvents": "1",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Acute kidney inury",
            "SeriousEventOrganSystem": "Renal and urinary disorders",
            "SeriousEventSourceVocabulary": "CTCAE (4.0)",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumEvents": "1",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Renal and urinary disorders, other",
            "SeriousEventOrganSystem": "Renal and urinary disorders",
            "SeriousEventSourceVocabulary": "CTCAE (4.0)",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumEvents": "1",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumEvents": "1",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Thromboembolic event",
            "SeriousEventOrganSystem": "Vascular disorders",
            "SeriousEventSourceVocabulary": "CTCAE (4.0)",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumEvents": "2",
                  "SeriousEventStatsNumAffected": "2",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumEvents": "1",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Vascular disorders, other",
            "SeriousEventOrganSystem": "Vascular disorders",
            "SeriousEventSourceVocabulary": "CTCAE (4.0)",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumEvents": "1",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Cardiac disorders, other",
            "SeriousEventOrganSystem": "Cardiac disorders",
            "SeriousEventSourceVocabulary": "CTCAE (4.0)",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumEvents": "1",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Ventricular Tachycardia",
            "SeriousEventOrganSystem": "Cardiac disorders",
            "SeriousEventSourceVocabulary": "CTCAE (4.0)",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumEvents": "1",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Adrenal Insufficiency",
            "SeriousEventOrganSystem": "Endocrine disorders",
            "SeriousEventSourceVocabulary": "CTCAE (4.0)",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumEvents": "2",
                  "SeriousEventStatsNumAffected": "2",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Blurred Vision",
            "SeriousEventOrganSystem": "Eye disorders",
            "SeriousEventSourceVocabulary": "CTCAE (4.0)",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumEvents": "1",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Abdominal pain",
            "SeriousEventOrganSystem": "Gastrointestinal disorders",
            "SeriousEventSourceVocabulary": "CTCAE (4.0)",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumEvents": "1",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumEvents": "1",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Ascites",
            "SeriousEventOrganSystem": "Gastrointestinal disorders",
            "SeriousEventSourceVocabulary": "CTCAE (4.0)",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumEvents": "1",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Colonic Obstruction",
            "SeriousEventOrganSystem": "Gastrointestinal disorders",
            "SeriousEventSourceVocabulary": "CTCAE (4.0)",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumEvents": "1",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Colonic Stenosis",
            "SeriousEventOrganSystem": "Gastrointestinal disorders",
            "SeriousEventSourceVocabulary": "CTCAE (4.0)",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumEvents": "1",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Ileus",
            "SeriousEventOrganSystem": "Gastrointestinal disorders",
            "SeriousEventSourceVocabulary": "CTCAE (4.0)",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumEvents": "1",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Pancreatitis",
            "SeriousEventOrganSystem": "Gastrointestinal disorders",
            "SeriousEventSourceVocabulary": "CTCAE (4.0)",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumEvents": "1",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Fatigue",
            "SeriousEventOrganSystem": "General disorders",
            "SeriousEventSourceVocabulary": "CTCAE (4.0)",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumEvents": "1",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Fever",
            "SeriousEventOrganSystem": "General disorders",
            "SeriousEventSourceVocabulary": "CTCAE (4.0)",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumEvents": "1",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "General Disorders and Administration site conditions",
            "SeriousEventOrganSystem": "General disorders",
            "SeriousEventSourceVocabulary": "CTCAE (4.0)",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumEvents": "3",
                  "SeriousEventStatsNumAffected": "3",
                  "SeriousEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Immune system disorders, other",
            "SeriousEventOrganSystem": "Immune system disorders",
            "SeriousEventSourceVocabulary": "CTCAE (4.0)",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumEvents": "1",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "appendicitis",
            "SeriousEventOrganSystem": "Infections and infestations",
            "SeriousEventSourceVocabulary": "CTCAE (4.0)",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumEvents": "1",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Urinary Tract Infection",
            "SeriousEventOrganSystem": "Infections and infestations",
            "SeriousEventSourceVocabulary": "CTCAE (4.0)",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumEvents": "1",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Dehydration",
            "SeriousEventOrganSystem": "Metabolism and nutrition disorders",
            "SeriousEventSourceVocabulary": "CTCAE (4.0)",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumEvents": "1",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Back pain",
            "SeriousEventOrganSystem": "Musculoskeletal and connective tissue disorders",
            "SeriousEventSourceVocabulary": "CTCAE (4.0)",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumEvents": "1",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Bone Pain",
            "SeriousEventOrganSystem": "Musculoskeletal and connective tissue disorders",
            "SeriousEventSourceVocabulary": "CTCAE (4.0)",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumEvents": "1",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Musculoskeletal and connective tissue disorder, other",
            "SeriousEventOrganSystem": "Musculoskeletal and connective tissue disorders",
            "SeriousEventSourceVocabulary": "CTCAE (4.0)",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumEvents": "1",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Myositis",
            "SeriousEventOrganSystem": "Musculoskeletal and connective tissue disorders",
            "SeriousEventSourceVocabulary": "CTCAE (4.0)",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumEvents": "0",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "42"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumEvents": "1",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "60"
                }
              ]
            }
          }
        ]
      },
      "OtherEventList": {
        "OtherEvent": [
          {
            "OtherEventTerm": "Anemia",
            "OtherEventOrganSystem": "Blood and lymphatic system disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "9",
                  "OtherEventStatsNumAffected": "9",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "8",
                  "OtherEventStatsNumAffected": "8",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "21",
                  "OtherEventStatsNumAffected": "21",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Blood and Lymphatic Systems Disorder, other",
            "OtherEventOrganSystem": "Blood and lymphatic system disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "2",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Febrile Neuropenia",
            "OtherEventOrganSystem": "Blood and lymphatic system disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Leukocytosis",
            "OtherEventOrganSystem": "Blood and lymphatic system disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "2",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Cardiac disorders, other",
            "OtherEventOrganSystem": "Cardiac disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "palpitations",
            "OtherEventOrganSystem": "Cardiac disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Sinus Bradycardia",
            "OtherEventOrganSystem": "Cardiac disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Sinus Tachycardia",
            "OtherEventOrganSystem": "Cardiac disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "2",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "2",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "4",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Ventricular Tachycardia",
            "OtherEventOrganSystem": "Cardiac disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Ear and Labyrinth disorders, other",
            "OtherEventOrganSystem": "Ear and labyrinth disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Endocrine Disorders-other",
            "OtherEventOrganSystem": "Endocrine disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Hyperparathyroidism",
            "OtherEventOrganSystem": "Endocrine disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Hyperthyroidism",
            "OtherEventOrganSystem": "Endocrine disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "3",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "2",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "2",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Hypothyroidism",
            "OtherEventOrganSystem": "Endocrine disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "2",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "2",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "7",
                  "OtherEventStatsNumAffected": "7",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Abdominal Pain",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "5",
                  "OtherEventStatsNumAffected": "5",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "5",
                  "OtherEventStatsNumAffected": "5",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "constipation",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "5",
                  "OtherEventStatsNumAffected": "5",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "6",
                  "OtherEventStatsNumAffected": "6",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "6",
                  "OtherEventStatsNumAffected": "6",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "diarrhea",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "7",
                  "OtherEventStatsNumAffected": "7",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "2",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "6",
                  "OtherEventStatsNumAffected": "6",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "dry mouth",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "4",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "flatulance",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "gastrointestinal disorders-other",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "2",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "4",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "non-cardiac chest pain",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "2",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "allergic reaction",
            "OtherEventOrganSystem": "Immune system disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "tooth infection",
            "OtherEventOrganSystem": "Infections and infestations",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "vaginal infection",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Bruising",
            "OtherEventOrganSystem": "Injury, poisoning and procedural complications",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "fracture",
            "OtherEventOrganSystem": "Injury, poisoning and procedural complications",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "2",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "activated partial thromboplastin time prolonged",
            "OtherEventOrganSystem": "Investigations",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "6",
                  "OtherEventStatsNumAffected": "6",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "7",
                  "OtherEventStatsNumAffected": "7",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "8",
                  "OtherEventStatsNumAffected": "8",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Alanine aminotranferase increased",
            "OtherEventOrganSystem": "Investigations",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "5",
                  "OtherEventStatsNumAffected": "5",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "4",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Alkaline Phosphatase increased",
            "OtherEventOrganSystem": "Investigations",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "4",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "12",
                  "OtherEventStatsNumAffected": "12",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "7",
                  "OtherEventStatsNumAffected": "7",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Aspartate aminotransferase increased",
            "OtherEventOrganSystem": "Investigations",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "7",
                  "OtherEventStatsNumAffected": "7",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "6",
                  "OtherEventStatsNumAffected": "6",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "creatinine increased",
            "OtherEventOrganSystem": "Investigations",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "2",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "2",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "5",
                  "OtherEventStatsNumAffected": "5",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "INR increased",
            "OtherEventOrganSystem": "Investigations",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "4",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "4",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "6",
                  "OtherEventStatsNumAffected": "6",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Lymphocyte count decreased",
            "OtherEventOrganSystem": "Investigations",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "3",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "6",
                  "OtherEventStatsNumAffected": "6",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "10",
                  "OtherEventStatsNumAffected": "10",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "dehydration",
            "OtherEventOrganSystem": "Metabolism and nutrition disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "6",
                  "OtherEventStatsNumAffected": "6",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "hypercalcemia",
            "OtherEventOrganSystem": "Metabolism and nutrition disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "hyperglycemia",
            "OtherEventOrganSystem": "Metabolism and nutrition disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "6",
                  "OtherEventStatsNumAffected": "6",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "3",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "8",
                  "OtherEventStatsNumAffected": "8",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "hyperkalemia",
            "OtherEventOrganSystem": "Metabolism and nutrition disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "3",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "hypoalbumenia",
            "OtherEventOrganSystem": "Metabolism and nutrition disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "3",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "5",
                  "OtherEventStatsNumAffected": "5",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "8",
                  "OtherEventStatsNumAffected": "8",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "hypocalcemia",
            "OtherEventOrganSystem": "Metabolism and nutrition disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "4",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "hypokalemia",
            "OtherEventOrganSystem": "Metabolism and nutrition disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "4",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "hyponatremia",
            "OtherEventOrganSystem": "Metabolism and nutrition disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "5",
                  "OtherEventStatsNumAffected": "5",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "8",
                  "OtherEventStatsNumAffected": "8",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "8",
                  "OtherEventStatsNumAffected": "8",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "arthralgia",
            "OtherEventOrganSystem": "Musculoskeletal and connective tissue disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "3",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "3",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "back pain",
            "OtherEventOrganSystem": "Musculoskeletal and connective tissue disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "7",
                  "OtherEventStatsNumAffected": "7",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "8",
                  "OtherEventStatsNumAffected": "8",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "chest wall pain",
            "OtherEventOrganSystem": "Musculoskeletal and connective tissue disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "3",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "3",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "musculoskeletal and connective tissue disorder-other",
            "OtherEventOrganSystem": "Musculoskeletal and connective tissue disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "2",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "2",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "7",
                  "OtherEventStatsNumAffected": "7",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "pain in extremity",
            "OtherEventOrganSystem": "Musculoskeletal and connective tissue disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "3",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "4",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "6",
                  "OtherEventStatsNumAffected": "6",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "tumor pain",
            "OtherEventOrganSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "2",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "dizziness",
            "OtherEventOrganSystem": "Nervous system disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "headache",
            "OtherEventOrganSystem": "Nervous system disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "4",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "2",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "nervous system disorders, other",
            "OtherEventOrganSystem": "Nervous system disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "2",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "neuralgia",
            "OtherEventOrganSystem": "Nervous system disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "confusion",
            "OtherEventOrganSystem": "Psychiatric disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "insomnia",
            "OtherEventOrganSystem": "Psychiatric disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "2",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "4",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Proteinuria",
            "OtherEventOrganSystem": "Renal and urinary disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "URINARY URGENCY",
            "OtherEventOrganSystem": "Renal and urinary disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "cough",
            "OtherEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "9",
                  "OtherEventStatsNumAffected": "9",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "7",
                  "OtherEventStatsNumAffected": "7",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "7",
                  "OtherEventStatsNumAffected": "7",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "dyspnea",
            "OtherEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "6",
                  "OtherEventStatsNumAffected": "6",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "4",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "5",
                  "OtherEventStatsNumAffected": "5",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Laryngeal hemmorhage",
            "OtherEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "pleural effusion",
            "OtherEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "2",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Postnasal drip",
            "OtherEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "respiratory, thoracic, and mediastinal disorders, other",
            "OtherEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "4",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "erythmea multiforme",
            "OtherEventOrganSystem": "Skin and subcutaneous tissue disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Pruritis",
            "OtherEventOrganSystem": "Skin and subcutaneous tissue disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "3",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "6",
                  "OtherEventStatsNumAffected": "6",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "rash maculo-papular",
            "OtherEventOrganSystem": "Skin and subcutaneous tissue disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "7",
                  "OtherEventStatsNumAffected": "7",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Hot flashes",
            "OtherEventOrganSystem": "Vascular disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Hypertension",
            "OtherEventOrganSystem": "Vascular disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "2",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "8",
                  "OtherEventStatsNumAffected": "8",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Hypotension",
            "OtherEventOrganSystem": "Vascular disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Blurred vision",
            "OtherEventOrganSystem": "Eye disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "photophobia",
            "OtherEventOrganSystem": "Eye disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Dental caries",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Dyspepsia",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Gastric ulcer",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Gastritis",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "gastroesophogeal reflux",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "2",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Mucositis oral",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Nausea",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "10",
                  "OtherEventStatsNumAffected": "10",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "3",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "9",
                  "OtherEventStatsNumAffected": "9",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "rectal pain",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Vomiting",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "4",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "4",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "chills",
            "OtherEventOrganSystem": "General disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "2",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "5",
                  "OtherEventStatsNumAffected": "5",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Edema limbs",
            "OtherEventOrganSystem": "General disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "3",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "2",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "6",
                  "OtherEventStatsNumAffected": "6",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Fatigue",
            "OtherEventOrganSystem": "General disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "2",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "flu like symptoms",
            "OtherEventOrganSystem": "General disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "general disorders-other",
            "OtherEventOrganSystem": "General disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "3",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "5",
                  "OtherEventStatsNumAffected": "5",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Hypothermia",
            "OtherEventOrganSystem": "General disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "localized edema",
            "OtherEventOrganSystem": "General disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "2",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "malaise",
            "OtherEventOrganSystem": "General disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Pain",
            "OtherEventOrganSystem": "General disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "2",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "serum sickness",
            "OtherEventOrganSystem": "Immune system disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "infections and infestations-other",
            "OtherEventOrganSystem": "Infections and infestations",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "2",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "papulopustular rash",
            "OtherEventOrganSystem": "Infections and infestations",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "2",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "skin infection",
            "OtherEventOrganSystem": "Infections and infestations",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "upper respiratory infection",
            "OtherEventOrganSystem": "Infections and infestations",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "4",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Blood bilirubin increased",
            "OtherEventOrganSystem": "Investigations",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "CPK increased",
            "OtherEventOrganSystem": "Investigations",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "2",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "investigations-other",
            "OtherEventOrganSystem": "Investigations",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "3",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "lymphocyte count increased",
            "OtherEventOrganSystem": "Investigations",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "3",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "neutrophil count decreased",
            "OtherEventOrganSystem": "Investigations",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "2",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "platelet count decreased",
            "OtherEventOrganSystem": "Investigations",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "3",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "3",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "weight loss",
            "OtherEventOrganSystem": "Investigations",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "4",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "white blood cell decreased",
            "OtherEventOrganSystem": "Investigations",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "4",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "anorexia",
            "OtherEventOrganSystem": "Metabolism and nutrition disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "6",
                  "OtherEventStatsNumAffected": "6",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "2",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "8",
                  "OtherEventStatsNumAffected": "8",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "bone pain",
            "OtherEventOrganSystem": "Musculoskeletal and connective tissue disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "2",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "buttock pain",
            "OtherEventOrganSystem": "Musculoskeletal and connective tissue disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "flank pain",
            "OtherEventOrganSystem": "Musculoskeletal and connective tissue disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "generalized muscle weakness",
            "OtherEventOrganSystem": "Musculoskeletal and connective tissue disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "2",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "joint effusion",
            "OtherEventOrganSystem": "Musculoskeletal and connective tissue disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "joint range of motion decreased",
            "OtherEventOrganSystem": "Musculoskeletal and connective tissue disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "myalgia",
            "OtherEventOrganSystem": "Musculoskeletal and connective tissue disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "4",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "2",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "neck pain",
            "OtherEventOrganSystem": "Musculoskeletal and connective tissue disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "soft tissue necrosis upper limb",
            "OtherEventOrganSystem": "Musculoskeletal and connective tissue disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "neoplasms, benign, malignant, and unspecified",
            "OtherEventOrganSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "dysesthesia",
            "OtherEventOrganSystem": "Nervous system disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "dysgeusia",
            "OtherEventOrganSystem": "Nervous system disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Paresthesia",
            "OtherEventOrganSystem": "Nervous system disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "peripheral sensory neuropathy",
            "OtherEventOrganSystem": "Nervous system disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "3",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "presyncope",
            "OtherEventOrganSystem": "Nervous system disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "anxiety",
            "OtherEventOrganSystem": "Psychiatric disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "3",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "depression",
            "OtherEventOrganSystem": "Psychiatric disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "2",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "psychiatric disorders-other",
            "OtherEventOrganSystem": "Psychiatric disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "suicidal ideation",
            "OtherEventOrganSystem": "Psychiatric disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "allergic rhinitis",
            "OtherEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "pneumonitis",
            "OtherEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "productive cough",
            "OtherEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "0",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "sore throat",
            "OtherEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "rash acneiform",
            "OtherEventOrganSystem": "Skin and subcutaneous tissue disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "skin and subcutaneous tissue disorders",
            "OtherEventOrganSystem": "Skin and subcutaneous tissue disorders",
            "OtherEventSourceVocabulary": "CTCAE (4.0)",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumEvents": "5",
                  "OtherEventStatsNumAffected": "5",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumEvents": "1",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "42"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumEvents": "3",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "60"
                }
              ]
            }
          }
        ]
      }
    },
    "MoreInfoModule": {
      "CertainAgreement": {
        "AgreementPISponsorEmployee": "No",
        "AgreementRestrictiveAgreement": "No"
      },
      "PointOfContact": {
        "PointOfContactTitle": "Research Manager",
        "PointOfContactOrganization": "Sarcoma Alliance for Research Through Collaboration",
        "PointOfContactEMail": "sarc@sarctrials.org",
        "PointOfContactPhone": "734-930-7600"
      }
    }
  },
  "DocumentSection": {
    "LargeDocumentModule": {
      "LargeDocList": {
        "LargeDoc": [
          {
            "LargeDocTypeAbbrev": "Prot_SAP",
            "LargeDocHasProtocol": "Yes",
            "LargeDocHasSAP": "Yes",
            "LargeDocHasICF": "No",
            "LargeDocLabel": "Study Protocol and Statistical Analysis Plan",
            "LargeDocDate": "January 9, 2020",
            "LargeDocUploadDate": "07/08/2020 13:52",
            "LargeDocFilename": "Prot_SAP_000.pdf"
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000012509",
            "ConditionMeshTerm": "Sarcoma"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000018204",
            "ConditionAncestorTerm": "Neoplasms, Connective and Soft Tissue"
          },
          {
            "ConditionAncestorId": "D000009370",
            "ConditionAncestorTerm": "Neoplasms by Histologic Type"
          },
          {
            "ConditionAncestorId": "D000009369",
            "ConditionAncestorTerm": "Neoplasms"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M14479",
            "ConditionBrowseLeafName": "Sarcoma",
            "ConditionBrowseLeafAsFound": "Sarcoma",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M14486",
            "ConditionBrowseLeafName": "Osteosarcoma",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M19502",
            "ConditionBrowseLeafName": "Neoplasms, Connective and Soft Tissue",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M11467",
            "ConditionBrowseLeafName": "Neoplasms by Histologic Type",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "T4340",
            "ConditionBrowseLeafName": "Osteosarcoma",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "T5284",
            "ConditionBrowseLeafName": "Soft Tissue Sarcoma",
            "ConditionBrowseLeafAsFound": "Sarcoma",
            "ConditionBrowseLeafRelevance": "high"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC04",
            "ConditionBrowseBranchName": "Neoplasms"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "Rare",
            "ConditionBrowseBranchName": "Rare Diseases"
          }
        ]
      }
    },
    "InterventionBrowseModule": {
      "InterventionMeshList": {
        "InterventionMesh": [
          {
            "InterventionMeshId": "C000582435",
            "InterventionMeshTerm": "Pembrolizumab"
          }
        ]
      },
      "InterventionAncestorList": {
        "InterventionAncestor": [
          {
            "InterventionAncestorId": "D000074322",
            "InterventionAncestorTerm": "Antineoplastic Agents, Immunological"
          },
          {
            "InterventionAncestorId": "D000000970",
            "InterventionAncestorTerm": "Antineoplastic Agents"
          }
        ]
      },
      "InterventionBrowseLeafList": {
        "InterventionBrowseLeaf": [
          {
            "InterventionBrowseLeafId": "M289070",
            "InterventionBrowseLeafName": "Pembrolizumab",
            "InterventionBrowseLeafAsFound": "200",
            "InterventionBrowseLeafRelevance": "high"
          },
          {
            "InterventionBrowseLeafId": "M3377",
            "InterventionBrowseLeafName": "Antibodies",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M9336",
            "InterventionBrowseLeafName": "Immunoglobulins",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M1346",
            "InterventionBrowseLeafName": "Antineoplastic Agents, Immunological",
            "InterventionBrowseLeafRelevance": "low"
          }
        ]
      },
      "InterventionBrowseBranchList": {
        "InterventionBrowseBranch": [
          {
            "InterventionBrowseBranchAbbrev": "ANeo",
            "InterventionBrowseBranchName": "Antineoplastic Agents"
          },
          {
            "InterventionBrowseBranchAbbrev": "All",
            "InterventionBrowseBranchName": "All Drugs and Chemicals"
          }
        ]
      }
    }
  }
}